Fatty Acid Synthase Inhibitor Platensimycin Intervenes the Development of Nonalcoholic Fatty Liver Disease in a Mouse Model.Published in:Biomedicines, 2022, v. 10, n. 1, p. 5, doi. 10.3390/biomedicines10010005By:Su, Meng;Cao, Danfeng;Wang, Zhe;Duan, Yanwen;Huang, YongPublication type:Article